US Stock MarketDetailed Quotes

CORT Corcept Therapeutics

Watchlist

34.570
+0.690+2.04%

Close Jul 22 16:00 ET

34.970
+0.400+1.16%

Post 17:14 ET

3.60BMarket Cap32.92P/E (TTM)

Corcept Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-8.48%23.76M

5.58%127.04M

-82.37%5.89M

57.24%52.91M

134.40%42.29M

-26.36%25.96M

-28.33%120.32M

-32.45%33.39M

-30.91%33.65M

-59.31%18.04M

Net income from continuing operations

74.83%27.76M

4.66%106.14M

88.87%31.36M

-9.33%31.38M

0.42%27.53M

-30.35%15.88M

-9.86%101.42M

-48.21%16.6M

13.58%34.61M

3.35%27.41M

Depreciation and amortization

-79.16%179K

-31.46%2.36M

-48.53%630K

-77.53%169K

5.39%704K

7.11%859K

-0.86%3.45M

1.49%1.22M

-2.46%752K

-11.64%668K

Deferred tax

-6.48%-7.16M

13.01%-29.49M

17.80%-3.67M

0.18%-8.86M

3.69%-10.24M

32.30%-6.73M

-880.14%-33.91M

-294.30%-4.47M

-315.99%-8.87M

-422.22%-10.63M

Other non cash items

----

-1,196.81%-2.75M

----

-81.18%251K

-40.17%764K

Change In working capital

-217.54%-7.41M

48.37%8.22M

-415.18%-32.3M

651.48%20.1M

230.90%14.11M

-35.09%6.31M

1,288.63%5.54M

478.60%10.25M

-441.20%-3.64M

-861.30%-10.78M

-Change in receivables

-326.33%-6.4M

42.26%-10.07M

58.47%-6.5M

-65.84%-2.07M

100.41%4K

-435.57%-1.5M

-1,121.58%-17.43M

-1,300.45%-15.64M

-212.41%-1.25M

81.81%-986K

-Change in inventory

76.16%983K

5.50%1.27M

163.20%329K

-229.83%-544K

12.71%922K

442.33%558K

-65.19%1.2M

-84.16%125K

-47.43%419K

-17.54%818K

-Change in prepaid assets

395.47%3.61M

-76.96%-11.6M

-209.92%-6.38M

24.94%-6.43M

112.73%482K

8,200.00%729K

-63.68%-6.56M

437.95%5.81M

-3,455.60%-8.57M

-571.36%-3.79M

-Change in payables and accrued expense

-180.29%-5.69M

-3.41%31.39M

-180.85%-18.19M

362.81%29.22M

311.60%13.28M

-28.89%7.09M

1,892.83%32.5M

578.88%22.5M

5,317.36%6.31M

-233.82%-6.28M

-Change in other current assets

--153K

24.91%-1.48M

----

--0

-203.03%-1.98M

----

-Change in other current liabilities

86.80%-75K

41.38%-1.29M

86.88%-74K

87.07%-72K

-4.17%-575K

-7.98%-568K

-8.59%-2.2M

-8.46%-564K

-8.58%-557K

-8.66%-552K

Cash from discontinued investing activities

Operating cash flow

-8.48%23.76M

5.58%127.04M

-82.37%5.89M

57.24%52.91M

134.40%42.29M

-26.36%25.96M

-28.33%120.32M

-32.45%33.39M

-30.91%33.65M

-59.31%18.04M

Investing cash flow

Cash flow from continuing investing activities

-104.34%-9.01M

179.51%90.91M

199.17%17.1M

-2,187.47%-109.57M

42.35%-24.1M

510.87%207.48M

-183.99%-114.33M

-112.27%-17.24M

81.44%-4.79M

-268.94%-41.8M

Net PPE purchase and sale

----

66.34%-139K

--0

89.46%-37K

----

11.94%-413K

52.31%-31K

-120.75%-351K

84.03%-19K

Net investment purchase and sale

-104.34%-9.01M

179.92%91.05M

199.35%17.1M

-2,367.52%-109.53M

42.57%-24M

510.97%207.48M

-183.40%-113.91M

-112.25%-17.21M

82.69%-4.44M

-268.06%-41.78M

Cash from discontinued investing activities

Investing cash flow

-104.34%-9.01M

179.51%90.91M

199.17%17.1M

-2,187.47%-109.57M

42.35%-24.1M

510.87%207.48M

-183.99%-114.33M

-112.27%-17.24M

81.44%-4.79M

-268.94%-41.8M

Financing cash flow

Cash flow from continuing financing activities

-400.00%-543K

-760.47%-148.72M

1,355.74%766K

71.95%-3.92M

-5,188.61%-145.75M

135.77%181K

94.29%-17.28M

99.97%-61K

40.95%-13.96M

89.41%-2.76M

Net common stock issuance

----

---145.43M

--0

----

--0

----

Proceeds from stock option exercised by employees

-13.91%1.21M

32.64%5.81M

124.33%1.76M

-38.83%4.2M

66.54%-1.55M

1.95%1.41M

-73.01%4.38M

-74.24%785K

56.01%6.86M

-197.81%-4.64M

Net other financing activities

-43.00%-1.76M

57.97%-9.11M

-17.61%-995K

----

34.96%-1.23M

5.12%-21.67M

66.38%-846K

----

Cash from discontinued financing activities

Financing cash flow

-400.00%-543K

-760.47%-148.72M

1,355.74%766K

71.95%-3.92M

-5,188.61%-145.75M

135.77%181K

94.29%-17.28M

99.97%-61K

40.95%-13.96M

89.41%-2.76M

Net cash flow

Beginning cash position

104.36%135.55M

-14.54%66.33M

122.52%111.8M

387.68%172.38M

384.86%299.94M

-14.54%66.33M

1.87%77.62M

-46.94%50.24M

-62.96%35.35M

18.10%61.86M

Current changes in cash

-93.92%14.2M

713.24%69.22M

47.65%23.75M

-506.64%-60.58M

-381.09%-127.57M

1,582.79%233.61M

-891.03%-11.29M

194.23%16.09M

2,107.68%14.9M

-161.59%-26.52M

End cash Position

-50.07%149.75M

104.36%135.55M

122.52%111.8M

387.68%172.38M

384.86%299.94M

-14.54%66.33M

-46.94%50.24M

-62.96%35.35M

Free cash flow

-8.48%23.76M

5.83%126.9M

-82.35%5.89M

58.79%52.87M

134.08%42.18M

-26.33%25.96M

-28.38%119.91M

-32.42%33.36M

-31.41%33.3M

-59.25%18.02M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-8.48%23.76M	5.58%127.04M	-82.37%5.89M	57.24%52.91M	134.40%42.29M	-26.36%25.96M	-28.33%120.32M	-32.45%33.39M	-30.91%33.65M	-59.31%18.04M
Net income from continuing operations	74.83%27.76M	4.66%106.14M	88.87%31.36M	-9.33%31.38M	0.42%27.53M	-30.35%15.88M	-9.86%101.42M	-48.21%16.6M	13.58%34.61M	3.35%27.41M
Depreciation and amortization	-79.16%179K	-31.46%2.36M	-48.53%630K	-77.53%169K	5.39%704K	7.11%859K	-0.86%3.45M	1.49%1.22M	-2.46%752K	-11.64%668K
Deferred tax	-6.48%-7.16M	13.01%-29.49M	17.80%-3.67M	0.18%-8.86M	3.69%-10.24M	32.30%-6.73M	-880.14%-33.91M	-294.30%-4.47M	-315.99%-8.87M	-422.22%-10.63M
Other non cash items	----	----	----	-1,196.81%-2.75M	----	----	----	----	-81.18%251K	-40.17%764K
Change In working capital	-217.54%-7.41M	48.37%8.22M	-415.18%-32.3M	651.48%20.1M	230.90%14.11M	-35.09%6.31M	1,288.63%5.54M	478.60%10.25M	-441.20%-3.64M	-861.30%-10.78M
-Change in receivables	-326.33%-6.4M	42.26%-10.07M	58.47%-6.5M	-65.84%-2.07M	100.41%4K	-435.57%-1.5M	-1,121.58%-17.43M	-1,300.45%-15.64M	-212.41%-1.25M	81.81%-986K
-Change in inventory	76.16%983K	5.50%1.27M	163.20%329K	-229.83%-544K	12.71%922K	442.33%558K	-65.19%1.2M	-84.16%125K	-47.43%419K	-17.54%818K
-Change in prepaid assets	395.47%3.61M	-76.96%-11.6M	-209.92%-6.38M	24.94%-6.43M	112.73%482K	8,200.00%729K	-63.68%-6.56M	437.95%5.81M	-3,455.60%-8.57M	-571.36%-3.79M
-Change in payables and accrued expense	-180.29%-5.69M	-3.41%31.39M	-180.85%-18.19M	362.81%29.22M	311.60%13.28M	-28.89%7.09M	1,892.83%32.5M	578.88%22.5M	5,317.36%6.31M	-233.82%-6.28M
-Change in other current assets	--153K	24.91%-1.48M	----	----	----	--0	-203.03%-1.98M	----	----	----
-Change in other current liabilities	86.80%-75K	41.38%-1.29M	86.88%-74K	87.07%-72K	-4.17%-575K	-7.98%-568K	-8.59%-2.2M	-8.46%-564K	-8.58%-557K	-8.66%-552K
Cash from discontinued investing activities
Operating cash flow	-8.48%23.76M	5.58%127.04M	-82.37%5.89M	57.24%52.91M	134.40%42.29M	-26.36%25.96M	-28.33%120.32M	-32.45%33.39M	-30.91%33.65M	-59.31%18.04M
Investing cash flow
Cash flow from continuing investing activities	-104.34%-9.01M	179.51%90.91M	199.17%17.1M	-2,187.47%-109.57M	42.35%-24.1M	510.87%207.48M	-183.99%-114.33M	-112.27%-17.24M	81.44%-4.79M	-268.94%-41.8M
Net PPE purchase and sale	----	66.34%-139K	--0	89.46%-37K	----	----	11.94%-413K	52.31%-31K	-120.75%-351K	84.03%-19K
Net investment purchase and sale	-104.34%-9.01M	179.92%91.05M	199.35%17.1M	-2,367.52%-109.53M	42.57%-24M	510.97%207.48M	-183.40%-113.91M	-112.25%-17.21M	82.69%-4.44M	-268.06%-41.78M
Cash from discontinued investing activities
Investing cash flow	-104.34%-9.01M	179.51%90.91M	199.17%17.1M	-2,187.47%-109.57M	42.35%-24.1M	510.87%207.48M	-183.99%-114.33M	-112.27%-17.24M	81.44%-4.79M	-268.94%-41.8M
Financing cash flow
Cash flow from continuing financing activities	-400.00%-543K	-760.47%-148.72M	1,355.74%766K	71.95%-3.92M	-5,188.61%-145.75M	135.77%181K	94.29%-17.28M	99.97%-61K	40.95%-13.96M	89.41%-2.76M
Net common stock issuance	----	---145.43M	--0	--0	----	----	--0	--0	--0	----
Proceeds from stock option exercised by employees	-13.91%1.21M	32.64%5.81M	124.33%1.76M	-38.83%4.2M	66.54%-1.55M	1.95%1.41M	-73.01%4.38M	-74.24%785K	56.01%6.86M	-197.81%-4.64M
Net other financing activities	-43.00%-1.76M	57.97%-9.11M	-17.61%-995K	----	----	34.96%-1.23M	5.12%-21.67M	66.38%-846K	----	----
Cash from discontinued financing activities
Financing cash flow	-400.00%-543K	-760.47%-148.72M	1,355.74%766K	71.95%-3.92M	-5,188.61%-145.75M	135.77%181K	94.29%-17.28M	99.97%-61K	40.95%-13.96M	89.41%-2.76M
Net cash flow
Beginning cash position	104.36%135.55M	-14.54%66.33M	122.52%111.8M	387.68%172.38M	384.86%299.94M	-14.54%66.33M	1.87%77.62M	-46.94%50.24M	-62.96%35.35M	18.10%61.86M
Current changes in cash	-93.92%14.2M	713.24%69.22M	47.65%23.75M	-506.64%-60.58M	-381.09%-127.57M	1,582.79%233.61M	-891.03%-11.29M	194.23%16.09M	2,107.68%14.9M	-161.59%-26.52M
End cash Position	-50.07%149.75M	104.36%135.55M	104.36%135.55M	122.52%111.8M	387.68%172.38M	384.86%299.94M	-14.54%66.33M	-14.54%66.33M	-46.94%50.24M	-62.96%35.35M
Free cash flow	-8.48%23.76M	5.83%126.9M	-82.35%5.89M	58.79%52.87M	134.08%42.18M	-26.33%25.96M	-28.38%119.91M	-32.42%33.36M	-31.41%33.3M	-59.25%18.02M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall